Search

everythinglearnresearchcommunity

for

Search:↓

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

The TRPV3 gene variant may cause the long-haired suri alpaca coat.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

An AI device for skin cancer was successfully integrated into the NHS, improving diagnosis accuracy and service capacity.

Genetic analysis is crucial for diagnosing and managing cerebral arteriopathy.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

AXR3 and SHY2 genes control the growth and timing of root hair development in plants.

TEDAR is crucial for skin cell differentiation and barrier formation.

The PCR technique can identify genetic differences in a wool-related gene among different sheep breeds, which may help improve wool and pelt quality.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Trichoscopic examination is crucial for diagnosing congenital triangular alopecia.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Researchers converted human embryonic stem cells into trophoblast stem cells using specific transcription factors.

Tretinoin alone is more effective than combined with microdermabrasion for long-term alopecia areata treatment.